- Report
- August 2026
- 196 Pages
Global
From €5255EUR$5,850USD£4,501GBP
- Report
- August 2026
- 732 Pages
Global
From €5255EUR$5,850USD£4,501GBP
- Report
- May 2026
- 120 Pages
Global
From €4267EUR$4,750USD£3,655GBP
- Report
- July 2026
- 160 Pages
Global
From €3728EUR$4,150USD£3,193GBP
- Report
- May 2026
- 146 Pages
Global
From €3548EUR$3,950USD£3,039GBP
- Report
- May 2026
- 148 Pages
Global
From €3548EUR$3,950USD£3,039GBP
- Report
- May 2026
- 147 Pages
Global
From €3548EUR$3,950USD£3,039GBP
- Report
- May 2026
- 148 Pages
Global
From €3548EUR$3,950USD£3,039GBP
- Report
- May 2026
- 156 Pages
Global
From €3548EUR$3,950USD£3,039GBP
- Report
- June 2026
- 160 Pages
Global
From €2515EUR$2,799USD£2,154GBP
€3143EUR$3,499USD£2,692GBP
- Report
- April 2026
- 160 Pages
Global
From €2982EUR$3,320USD£2,555GBP
€3728EUR$4,150USD£3,193GBP
- Report
- April 2026
- 160 Pages
Global
From €2982EUR$3,320USD£2,555GBP
€3728EUR$4,150USD£3,193GBP
- Report
- October 2025
- 160 Pages
Global
From €2839EUR$3,160USD£2,432GBP
€3548EUR$3,950USD£3,039GBP
- Report
- February 2026
- 82 Pages
Global
From €3500EUR$4,174USD£3,103GBP
- Report
- May 2026
- 130 Pages
Global
From €4357EUR$4,850USD£3,732GBP
- Report
- December 2025
- 150 Pages
Global
From €4357EUR$4,850USD£3,732GBP
- Report
- September 2025
- 150 Pages
Global
From €4357EUR$4,850USD£3,732GBP
- Report
- October 2025
- 90 Pages
Global
From €4043EUR$4,500USD£3,463GBP
- Report
- August 2025
- 150 Pages
United States
From €5345EUR$5,950USD£4,578GBP
- Report
- August 2025
- 130 Pages
Europe
From €3593EUR$4,000USD£3,078GBP

Biomarker Discovery is a field of research that focuses on the identification and characterization of biomarkers, which are biological molecules that can be used to measure and monitor the progression of a disease or condition. Biomarkers can be used to diagnose, predict, and monitor the effectiveness of treatments. They can also be used to identify individuals at risk of developing a disease or condition.
Biomarker Discovery is a rapidly growing field, with many companies investing in research and development. Companies such as Illumina, Qiagen, and Thermo Fisher Scientific are leading the way in developing new technologies and products for biomarker discovery. Other companies such as Roche, Abbott, and Agilent Technologies are also investing in biomarker discovery, offering a range of products and services. Show Less Read more